30/04/2026
If you look closely, global aseptic frameworks are more aligned than they first appeared.
Across guidance from the U.S. Food and Drug Administration, European Medicines Agency, World Health Organization, and Pharmaceutical Inspection Co-operation Scheme, there is a consistent scientific foundation:
- Human intervention remains a primary contamination risk
- Contamination control should be science- and risk-based
- Barrier technologies are widely recognized as effective mitigation strategies
In fact, industry guidance consistently emphasizes the role of separative technologies such as isolators and RABS in reducing contamination risk from operators.
At the same time, differences emerge, not in what needs to be achieved, but in how it is demonstrated.
Some frameworks are more prescriptive.
Others rely more on performance-based justification.
For manufacturers, this means navigating both science and interpretation.
If you want a structured comparison of how these expectations apply specifically to aseptic barrier systems (isolators and RABS), we’ve compiled it here: https://www.escopharma.com/pdf/brochures/esco-healthcare-product-guide?utm_source=chatgpt.com
